Clinical Trial Update: Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a microbubble-enhanced clot-busting treatment for acute ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: ImaRx Therapeutics | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: TERMINATED